Is the CEO of West Pharma retiring?
Eric M. Green planned his retirement from his roles as President, Chief Executive Officer, and Board Chair of West Pharmaceutical Services. Following a comprehensive global search conducted by the board of directors, Michel Lagarde—formerly serving in senior executive operations capacities at Thermo Fisher Scientific—was appointed as the new President and Chief Executive Officer to steer the global injectable drug delivery enterprise into its next chapter.
Related FAQs
West Pharmaceutical Services, Inc.
Plant managers and manufacturing facility directors at Dana Incorporated earn comprehensive executive salaries that reflect the immense responsibilities of overseeing automotive component production lines, supply chain logistics, and industrial plant...
Wall Street equity analysts tracking West Pharmaceutical Services (traded on the NYSE under the ticker WST) maintain a generally favorable outlook, with consensus 12-month target prices clustering around an average of $320 to $340 per share.
The global pharmaceutical sector features resilient corporate giants delivering strong financial returns through innovative drug portfolios and robust generic manufacturing networks.
West Pharmaceutical Services (NYSE: WST) generally receives strong buy or moderate buy recommendations from healthcare and life sciences sector analysts.
West Pharmaceutical Services is widely recognized as an exceptional, high-quality enterprise specializing in innovative component design and delivery systems for injectable drugs and healthcare products.
West Pharmaceutical Services maintains a strong future growth outlook driven by surging global demand for high-value containment and delivery systems supporting advanced biologics, injectable drugs, and GLP-1 therapies.
Western Midstream Partners, LP is an enterprise focused on the acquisition, ownership, development, and operation of midstream energy assets, including natural gas gathering, compression, treating, processing, and transportation systems.
West Pharmaceutical Services (NYSE: WST) is widely regarded by equity research analysts as a high-quality, fundamentally sound investment within the specialized healthcare and medical component sector.
Earning seven hundred thousand dollars a year is extremely rare for a standard commercial airline pilot, though a small fraction of elite, highly senior captains at major legacy carriers can approach or occasionally exceed these figures when accounti...
West Pharmaceutical Services is a global leader in the design and manufacture of technologically advanced, high-quality containment and delivery systems for injectable medicines.
Western Digital Corporation has experienced fluctuating financial profitability, frequently cycling through periods of strong net income during memory upcycles and substantial GAAP net losses during industry downturns characterized by oversupply and ...